Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
51
pubmed:dateCreated
2010-1-18
pubmed:abstractText
Malignant hyperthermia (MH) and central core disease are related skeletal muscle diseases often linked to mutations in the type 1 ryanodine receptor (RYR1) gene, encoding for the Ca(2+) release channel of the sarcoplasmic reticulum (SR). In humans, the Y522S RYR1 mutation is associated with malignant hyperthermia susceptibility (MHS) and the presence in skeletal muscle fibers of core regions that lack mitochondria. In heterozygous Y522S knock-in mice (RYR1(Y522S/WT)), the mutation causes SR Ca(2+) leak and MHS. Here, we identified mitochondrial-deficient core regions in skeletal muscle fibers from RYR1(Y522S/WT) knock-in mice and characterized the structural and temporal aspects involved in their formation. Mitochondrial swelling/disruption, the initial detectable structural change observed in young-adult RYR1(Y522S/WT) mice (2 months), does not occur randomly but rather is confined to discrete areas termed presumptive cores. This localized mitochondrial damage is followed by local disruption/loss of nearby SR and transverse tubules, resulting in early cores (2-4 months) and small contracture cores characterized by extreme sarcomere shortening and lack of mitochondria. At later stages (1 year), contracture cores are extended, frequent, and accompanied by areas in which contractile elements are also severely compromised (unstructured cores). Based on these observations, we propose a possible series of events leading to core formation in skeletal muscle fibers of RYR1(Y522S/WT) mice: Initial mitochondrial/SR disruption in confined areas causes significant loss of local Ca(2+) sequestration that eventually results in the formation of contractures and progressive degradation of the contractile elements.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-11524458, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-12161072, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-12208234, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-12411788, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-12467748, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-130467, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-13396066, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-13696813, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-13818365, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-14209825, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-14334754, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-15347586, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-1589759, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-16284304, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-17631035, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-18394989, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-19037102, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-192412, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-19246389, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-19293339, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-2710154, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-3626847, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-5418397, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-7829078, http://linkedlifedata.com/resource/pubmed/commentcorrection/19966218-7964383
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
22
pubmed:volume
106
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
21996-2001
pubmed:dateRevised
2011-10-18
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Characterization and temporal development of cores in a mouse model of malignant hyperthermia.
pubmed:affiliation
Centro Scienze dell'Invecchiamento, Department of Basic and Applied Medical Sciences, Interuniversity Institute of Myology, Università Gabriele d'Annunzio, I-66013 Chieti, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural